Thromboxane A2 receptor-specific antagonism in hypothermic cardiopulmonary bypass

This publication has 9 references indexed in Scilit:

• Role of thromboxane A2 in the cardiovascular response to intracoronary C5a.
  Circulation Research, 1990
• The thromboxane receptor antagonist SQ 30,741 reduces myocardial infarct size in monkeys when given during reperfusion at a threshold dose for improving reflow during thrombolysis
  Journal of the American College of Cardiology, 1990
• Reduction of Myocardial Damage and Polymorphonuclear Leukocyte Accumulation Following Coronary Artery Occlusion and Reperfusion by the Thromboxane Receptor Antagonist BM 13.505
  Journal of Cardiovascular Pharmacology, 1989
• Complement depletion and persistent hemodynamic-hematologic responses in protamine-heparin reactions
  Journal of Surgical Research, 1988
• Acute pulmonary vasoconstriction and thromboxane release during protamine reversal of heparin anticoagulation in awake sheep. Evidence for the role of reactive oxygen metabolites following nonimmunological complement activation.
  Circulation Research, 1988
• Pulmonary hypertensive effect of heparin and protamine interaction: Evidence for thromboxane B2 release from the lung
  The American Journal of Surgery, 1987
• C5a and Thromboxane Generation Associated with Pulmonary Vaso- and Broncho-constriction during Protamine Reversal of Heparin
  Anesthesiology, 1987
• Effects of Protamine Administration after Cardiopulmonary Bypass on Complement, Blood Elements, and the Hemodynamic State
  The Annals of Thoracic Surgery, 1986
• Thromboxane synthesis by sources other than platelets in association with complement-induced pulmonary leukostasis and pulmonary hypertension in sheep.
  Circulation Research, 1983